Additionally, growing insights into the involvement of PD-associated genes such as SNCA, LRRK2, and CHCHD2 (Table 1) in mitochondrial dysfunction—and their intersections with sporadic PD (sPD)—are revealing new opportunities for mitochondrial-targeted therapeutic strategies. The gene discussed is LRRK2; the disease is Parkinson disease.